STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]
Shukla P +11 more
europepmc +1 more source
Comprehensive gut microbiota and metabolomics combined with network pharmacology reveal the effects of acupuncture treatment for chemotherapy-induced nausea and vomiting. [PDF]
Wang X, Fan Y, Xiang Y, Zhang S, Yang Y.
europepmc +1 more source
Olanzapine: An Antiemetic Option for Chemotherapy-Induced Nausea and Vomiting
Megan V. Brafford, Ashley E. Glode
openalex +2 more sources
Prevention of chemotherapy-induced nausea and vomiting with acupuncture
Tingting Ma +6 more
openalex +1 more source
Association of chemotherapy-induced nausea and vomiting or anorexia with plasma levels of five gastrointestinal peptides in patients receiving chemotherapy. [PDF]
Tatsuta R +9 more
europepmc +1 more source
A double-blind, multicentre comparison of intravenous dolasetron mesilate and metoclopramide in the prevention of nausea and vomiting in cancer patients receiving high-dose cisplatin chemotherapy [PDF]
Bastit, P. (P.) +10 more
core +1 more source
Efficacy of NEPA for prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic chemotherapy and usefulness of adding olanzapine for grade 2 or higher emesis. [PDF]
Na J, Kim JJ, Oh SB, Park K.
europepmc +1 more source
Chemotherapy-Induced Nausea and Vomiting (CINV) [PDF]
openaire +1 more source
Predictive factors of chemotherapy‑induced nausea and vomiting in elderly patients with gynecological cancer undergoing paclitaxel and carboplatin therapy: A retrospective study. [PDF]
Yao F, He L, Sun X.
europepmc +1 more source

